These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11353540)

  • 1. Synthesis and preclinical characterization of a paclitaxel prodrug with improved antitumor activity and water solubility.
    Niethammer A; Gaedicke G; Lode HN; Wrasidlo W
    Bioconjug Chem; 2001; 12(3):414-20. PubMed ID: 11353540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new prodrug of paclitaxel: synthesis of Protaxel.
    Seligson AL; Terry RC; Bressi JC; Douglass JG; Sovak M
    Anticancer Drugs; 2001 Apr; 12(4):305-13. PubMed ID: 11335786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel 2'-(N-methylpyridinium acetate) prodrug of paclitaxel induces superior antitumor responses in preclinical cancer models.
    Wrasidlo W; Gaedicke G; Guy RK; Renaud J; Pitsinos E; Nicolaou KC; Reisfeld RA; Lode HN
    Bioconjug Chem; 2002; 13(5):1093-9. PubMed ID: 12236791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of water-soluble paclitaxel prodrugs.
    Feng X; Yuan YJ; Wu JC
    Bioorg Med Chem Lett; 2002 Nov; 12(22):3301-3. PubMed ID: 12392737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-paclitaxel conjugates as drug delivery system: synthesis, self-assembly property, drug release, and antitumor activity.
    Wang Y; Xin D; Liu K; Zhu M; Xiang J
    Bioconjug Chem; 2009 Dec; 20(12):2214-21. PubMed ID: 19950889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel prodrug of paclitaxel that is cleaved by prostate-specific antigen: an in vitro and in vivo evaluation study.
    Elsadek B; Graeser R; Esser N; Schäfer-Obodozie C; Abu Ajaj K; Unger C; Warnecke A; Saleem T; El-Melegy N; Madkor H; Kratz F
    Eur J Cancer; 2010 Dec; 46(18):3434-44. PubMed ID: 20933385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of 2'-carbamate-linked and 2'-carbonate-linked prodrugs of paclitaxel: selective activation by the tumor-associated protease plasmin.
    de Groot FM; van Berkom LW; Scheeren HW
    J Med Chem; 2000 Aug; 43(16):3093-102. PubMed ID: 10956217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel approach of water-soluble paclitaxel prodrug with no auxiliary and no byproduct: design and synthesis of isotaxel.
    Hayashi Y; Skwarczynski M; Hamada Y; Sohma Y; Kimura T; Kiso Y
    J Med Chem; 2003 Aug; 46(18):3782-4. PubMed ID: 12930140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and evaluation of water-soluble morpholino-decorated paclitaxel prodrugs with remarkably decreased toxicity.
    Feng S; Chen K; Wang C; Jiang X; Dong H; Gong Z; Liu K
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3598-602. PubMed ID: 27311893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of taxoids 5. Synthesis and evaluation of novel water-soluble prodrugs of a 3'-desphenyl-3'-cyclopropyl analogue of docetaxel.
    Yamaguchi T; Harada N; Ozaki K; Arakawa H; Oda K; Nakanishi N; Tsujihara K; Hashiyama T
    Bioorg Med Chem Lett; 1999 Jun; 9(12):1639-44. PubMed ID: 10397492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balancing the efficacy vs. the toxicity of promiscuous natural products: Paclitaxel-based acid-labile lipophilic prodrugs as promising chemotherapeutics.
    Haider S; Penfornis P; Claudio PP; McChesney JD; Chittiboyina AG
    Eur J Med Chem; 2022 Jan; 227():113891. PubMed ID: 34656042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrolyzable hydrophobic taxanes: synthesis and anti-cancer activities.
    Ali S; Ahmad I; Peters A; Masters G; Minchey S; Janoff A; Mayhew E
    Anticancer Drugs; 2001 Feb; 12(2):117-28. PubMed ID: 11261884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma.
    Rango E; D'Antona L; Iovenitti G; Brai A; Mancini A; Zamperini C; Trivisani CI; Marianelli S; Fallacara AL; Molinari A; Cianciusi A; Schenone S; Perrotti N; Dreassi E; Botta M
    Eur J Med Chem; 2021 Nov; 223():113653. PubMed ID: 34161866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of paclitaxel-2'-glycinate conjugated to poly(ethylene glycol): a water-soluble prodrug.
    Pendri A; Conover CD; Greenwald RB
    Anticancer Drug Des; 1998 Jul; 13(5):387-95. PubMed ID: 9702205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
    Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
    Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, Biological Evaluation and Low-Toxic Formulation Development of Glycosylated Paclitaxel Prodrugs.
    Mao Y; Zhang Y; Luo Z; Zhan R; Xu H; Chen W; Huang H
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30563132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-tumor efficacy of 3-(2-Nitrophenyl) propionic acid-paclitaxel (NPPA-PTX): a novel paclitaxel bioreductive prodrug.
    Song P; Yao X; Zhong T; Zhang S; Guo Y; Ren W; Huang D; Duan XC; Yin YF; Zhang SS; Zhang X
    Oncotarget; 2016 Jul; 7(30):48467-48480. PubMed ID: 27366947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Well-Defined Polymer-Paclitaxel Prodrugs by a Grafting-from-Drug Approach.
    Louage B; Nuhn L; Risseeuw MD; Vanparijs N; De Coen R; Karalic I; Van Calenbergh S; De Geest BG
    Angew Chem Int Ed Engl; 2016 Sep; 55(39):11791-6. PubMed ID: 27560940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antitumor activities of amino acid prodrugs of amino-combretastatins.
    Ohsumi K; Hatanaka T; Nakagawa R; Fukuda Y; Morinaga Y; Suga Y; Nihei Y; Ohishi K; Akiyama Y; Tsuji T
    Anticancer Drug Des; 1999 Dec; 14(6):539-48. PubMed ID: 10834274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A paclitaxel prodrug with bifunctional folate and albumin binding moieties for both passive and active targeted cancer therapy.
    Shan L; Zhuo X; Zhang F; Dai Y; Zhu G; Yung BC; Fan W; Zhai K; Jacobson O; Kiesewetter DO; Ma Y; Gao G; Chen X
    Theranostics; 2018; 8(7):2018-2030. PubMed ID: 29556370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.